Induction Chemoradiation Is Not Superior to Induction Chemotherapy Alone in Stage IIIA Lung Cancer  Asad A. Shah, MD, Mark F. Berry, MD, Ching Tzao, MD,

Slides:



Advertisements
Similar presentations
Surgical Versus Medical Therapy for Prosthetic Valve Endocarditis: A Meta-Analysis of 32 Studies  Christos G. Mihos, DO, Romain Capoulade, PhD, Evin Yucel,
Advertisements

Jeffrey L. Port, MD, Robert J. Korst, MD, Paul C. Lee, MD, Amanda L
Outcomes of Major Lung Resection After Induction Therapy for Non-Small Cell Lung Cancer in Elderly Patients  Chi-Fu Jeffrey Yang, MD, Nicholas R. Mayne,
Lymphovascular Invasion as a Prognostic Indicator in Stage I Non-Small Cell Lung Cancer: A Systematic Review and Meta-Analysis  Nathan M. Mollberg, DO,
Masatsugu Hamaji, MD, Syed Osman Ali, MD, Bryan M. Burt, MD 
Survival After Surgical Resection for Lung Cancer in Patients With Chronic Obstructive Pulmonary Disease  Anders Bugge, MD, May Brit Lund, MD, PhD, Cathrine.
Thomas J. Birdas, MD, Richard P. M
Video-Assisted Thoracoscopic Surgery Versus Thoracotomy Lymph Node Dissection in Clinical Stage I Lung Cancer: A Meta-Analysis and System Review  Wenxiong.
Postoperative Atrial Fibrillation Prophylaxis After Lung Surgery: Systematic Review and Meta-Analysis  Lars Peter Riber, MD, PhD, Torben Bjerregaard Larsen,
Zhiqiang Xue, MD, Fengying Wu, MD, Karlyn E
Rajat Kalra, MBChB, Navkaranbir S
Trevor Williams, MD, MPH, Brian C
Elliot Wakeam, MD, MPH, Meredith Giuliani, MBBS, MEd, Natasha B
Chi-Fu Jeffrey Yang, MD, Derek Y. Chan, BSE, Paul J
The Effectiveness of Postoperative Radiotherapy in Patients With Completely Resected Thymoma: A Meta-Analysis  Dong Zhou, MD, Xu-Feng Deng, MD, Quan-Xing.
Lisa M. Brown, MD, MAS, David T. Cooke, MD, Elizabeth A. David, MD 
A Systematic Review of Pulmonary Embolism in Patients With Lung Cancer
Defining the Optimal Treatment of Locally Advanced Esophageal Cancer: A Systematic Review and Decision Analysis  Andrew J. Graham, MD, MS, Fiona M. Shrive,
Sean M. Bagshaw, MD, MS, P. Diane Galbraith, BN, MS, L
Salvage Resections for Recurrent or Persistent Cancer of the Proximal Esophagus After Chemoradiotherapy  Colin Schieman, MD, Dennis A. Wigle, MD, PhD,
Salvage Lung Resection After Definitive Radiation (>59 Gy) for Non-Small Cell Lung Cancer: Surgical and Oncologic Outcomes  Julie E. Bauman, MD, Michael.
Morbidity, Survival, and Site of Recurrence After Mediastinal Lymph-Node Dissection Versus Systematic Sampling After Complete Resection for Non-Small.
Video-Assisted Thoracic Surgery Lobectomy: Experience With 1,100 Cases
Clinical T2N0 Esophageal Cancer: Identifying Pretreatment Characteristics Associated With Pathologic Upstaging and the Potential Role for Induction Therapy 
Robert E. Freundlich, MD, MS, Michael D. Maile, MD, MS, Mark M
Induction Chemotherapy is Not Superior to a Surgery-First Strategy for Clinical N1 Non- Small Cell Lung Cancer  Paul J. Speicher, MD, Zachary W. Fitch,
Castigliano M. Bhamidipati, DO, MS, George J
Factors Predicting Recurrence and Postrecurrence Survival in Completely Resected Thymic Carcinoma  Yi-Ting Yen, MD, Wu-Wei Lai, MD, Kai-Wei Chang, MD,
Loretta Erhunmwunsee, MD, Brian C
Surgical Versus Medical Therapy for Prosthetic Valve Endocarditis: A Meta-Analysis of 32 Studies  Christos G. Mihos, DO, Romain Capoulade, PhD, Evin Yucel,
Adding Radiotherapy to Adjuvant Chemotherapy Does Not Improve Survival of Patients With N2 Lung Cancer  Justin A. Drake, MD, David C. Portnoy, MD, Kurt.
Michelle C. Ellis, MD, Brian S. Diggs, PhD, John T. Vetto, MD, Paul H
Treatment Modalities for T1N0 Esophageal Cancers: A Comparative Analysis of Local Therapy Versus Surgical Resection  Mark F. Berry, MD, Josiane Zeyer-Brunner,
Zheng-Zhe Feng, MD, Jian Shi, MD, Xue-Wei Zhao, MD, Zhi-Fei Xu, MD 
Trevor Williams, MD, MPH, Brian C
Chordae Replacement Versus Resection for Repair of Isolated Posterior Mitral Leaflet Prolapse: À Ègalité  Joerg Seeburger, MD, Volkmar Falk, MD, PhD,
Surgical Resection of Rare Esophageal Cancers
Asad A. Shah, MD, Mathias Worni, MD, MHS, Christopher R
Thomas J. Birdas, MD, Richard P. M
Impact of Lepidic Component Occupancy on Effects of Adjuvant Chemotherapy for Lung Adenocarcinoma  Shinsuke Sasada, MD, PhD, Yoshihiro Miyata, MD, PhD,
Use of Amiodarone After Major Lung Resection
Elliot Wakeam, MD, MPH, James P. Byrne, MD, Gail E
Alex K. Bryant, BS, Robert C. Mundt, HSDG, Ajay P. Sandhu, MD, James J
Mallory L. Irons, MD, MBE, J. William Gaynor, MD, Thomas L
Recurrence and Survival After Segmentectomy in Patients With Prior Lung Resection for Early-Stage Non-Small Cell Lung Cancer  Lisa M. Brown, MD, Brian.
Robert R. McMillan, MD, MPH, Camelia S. Sima, MD, MS, Nicole H
Comparison of Conservative Treatment and Thymectomy on Myasthenia Gravis Outcome  Emanuela Taioli, MD, PhD, Philip Kent Paschal, Bian Liu, PhD, Andrew.
Is There a Role for Cancer-Directed Surgery in Early-Stage Sarcomatoid or Biphasic Mesothelioma?  Samuel Kim, MD, David A. Bull, MD, Linda Garland, MD,
Risk Factors for Atrial Fibrillation After Lung Cancer Surgery: Analysis of The Society of Thoracic Surgeons General Thoracic Surgery Database  Mark Onaitis,
Differences in Patterns of Recurrence in Early-Stage Versus Locally Advanced Non- Small Cell Lung Cancer  Feiran Lou, MD, MS, Camelia S. Sima, MD, MS,
Lung Function and ECMO After Lung Transplantation
Masatsugu Hamaji, MD, Syed Osman Ali, MD, Bryan M. Burt, MD 
Coronary Artery Bypass Revascularization Using Bilateral Internal Thoracic Arteries in Diabetic Patients: A Systematic Review and Meta-Analysis  Kan Kajimoto,
Patient Preferences in Treatment Choices for Early-Stage Lung Cancer
Pulmonary Resection for Lung Cancer in Octogenarians
Sublobar Resection Provides an Equivalent Survival After Lobectomy in Elderly Patients With Early Lung Cancer  Jiro Okami, MD, PhD, Yuri Ito, PhD, Masahiko.
A Meta-Analysis of Postoperative Radiotherapy for Thymic Carcinoma
Impact of Pulmonary Function Measurements on Long-Term Survival After Lobectomy for Stage I Non-Small Cell Lung Cancer  Mark F. Berry, MD, Chi-Fu Jeffrey.
Jonathan D. Spicer, MD, PhD, Jitesh B. Shewale, BDS, PhD, David B
Phillip G. Rowse, MD, Dawn E
The Influence of Physician and Patient Gender on Risk Assessment for Lung Cancer Resection  Mark K. Ferguson, MD, Megan Huisingh-Scheetz, MD, MPH, Katherine.
What Is the Role of Minimally Invasive Mitral Valve Surgery in High-Risk Patients? A Meta-Analysis of Observational Studies  Marco Moscarelli, MD, Khalil.
Specialty Training and Mortality After Esophageal Cancer Resection
Shared Decision Making and Effective Risk Communication in the High-Risk Patient With Operable Stage I Non-Small Cell Lung Cancer  Pamela Samson, MD,
Effects of Delayed Surgical Resection on Short-Term and Long-Term Outcomes in Clinical Stage I Non-Small Cell Lung Cancer  Pamela Samson, MD, Aalok Patel,
Sagar U. Nigwekar, MD, Praveen Kandula, MD, MPH 
Hisato Takagi, MD, PhD, Masafumi Matsui, MD, Takuya Umemoto, MD, PhD 
Mark I. Block, MD  The Annals of Thoracic Surgery 
Lobectomy Versus Limited Resection in T1N0 Lung Cancer
Domenico Galetta, MD, PhD, Lorenzo Spaggiari, MD, PhD 
Presentation transcript:

Induction Chemoradiation Is Not Superior to Induction Chemotherapy Alone in Stage IIIA Lung Cancer  Asad A. Shah, MD, Mark F. Berry, MD, Ching Tzao, MD, PhD, Mihir Gandhi, MS, Mathias Worni, MD, Ricardo Pietrobon, MD, MPH, Thomas A. D'Amico, MD  The Annals of Thoracic Surgery  Volume 93, Issue 6, Pages 1807-1812 (June 2012) DOI: 10.1016/j.athoracsur.2012.03.018 Copyright © 2012 The Society of Thoracic Surgeons Terms and Conditions

Fig 1 Flow diagram of patients included in systematic review and meta-analysis. The Annals of Thoracic Surgery 2012 93, 1807-1812DOI: (10.1016/j.athoracsur.2012.03.018) Copyright © 2012 The Society of Thoracic Surgeons Terms and Conditions

Fig 2 Forest plot of overall survival of patients in randomized studies receiving induction chemotherapy versus induction chemoradiotherapy followed by resection. (CI = confidence interval; SE = standard error.) The Annals of Thoracic Surgery 2012 93, 1807-1812DOI: (10.1016/j.athoracsur.2012.03.018) Copyright © 2012 The Society of Thoracic Surgeons Terms and Conditions

Fig 3 Forest plot of overall survival of patients in retrospective studies receiving induction chemotherapy versus induction chemoradiotherapy followed by resection. (CI = confidence interval; SE = standard error.) The Annals of Thoracic Surgery 2012 93, 1807-1812DOI: (10.1016/j.athoracsur.2012.03.018) Copyright © 2012 The Society of Thoracic Surgeons Terms and Conditions